SOURCE: BioNeutral

September 08, 2010 07:00 ET

BioNeutral Appoints Wahlrich Group LLC as Its Marketing Agency

BioNeutral's Product Line to Be Handled by the Marketing Agency Responsible for Assisting Worldwide Brands

NEWARK, NJ--(Marketwire - September 8, 2010) -  BioNeutral Group, Inc. (OTCBB: BONU), a specialty chemical technology-based life science company, has reported substantial progress in developing a world class product line with performance characteristics which set new standards, and has engaged the Wahlrich Group to help the Company bring its products to market. "Wahlrich Group has agreed to provide their expertise in branding, communicating and positioning in the marketplace an integrated series of BioNeutral products. Wahlrich Group is a very successful firm that has helped develop extraordinarily successful brands," said Steve Browand, CEO.

"We believe that BioNeutral Group has the potential to create new and better positioned products which are supported by a substantive technology which differentiates their performance claims. BioNeutral's technology could help to bring products to market which could be as innovative as those offered by some of our largest clients," said Mike Wahl, CEO of Wahlrich Group. 

"Our newest formulations can be manufactured economically and we believe will outperform the competition. Wahlrich Group has the expertise to communicate that our technology has a meaningful performance difference, which we expect will result in dramatic sales," said Andy Kielbania, Chief Scientific Officer. 

Using its proprietary Ogiene™ technology, BioNeutral intends to focus on launching its first product line. The Ogiene™ family of products consists of a variety of multi-purpose cleaners and odor removers. The products neutralize many difficult odors without leaving any scent of their own, truly "neutralizing" many of the chemicals that can cause unpleasant odors, both natural and man-made. Even more, it is water-based and environmentally friendly, leaving no harmful residue. Future product expansions will include potential product offerings to healthcare/institutional, commercial and government/military.

About Wahlrich Group, LLC.
Headquartered in New York City, Wahlrich Group, LLC. is one of the leading full service in-store marketing agency providing brand communication, product presentation, and in-store environment solutions to leading retailers and brand manufacturers. Wahlrich Group specializes in all facets of in-store branding and communication, from designing and manufacturing the award winning display for the launch of Nintendo's Wii, to developing the branding strategy and packaging for Fiji Water. They are constantly on the leading edge of designing, manufacturing and implementing impactful solutions at the point of sale. For more information, see www.wahlrich.com

Forward-Looking Statements
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene and are not yet available for sale in the United States.

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risk, uncertainties and other factors that may cause the Company's actual performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions; government regulations; the ability of our management to successfully implement our business plan and strategy; our ability to fund our operations including the cost and availability of capital and credit; our ability to compete effectively including our ability to maintain and increase our market share in the markets in which we do business; and our ability to successfully develop and commercialize our products.

Contact Information

  • Investor Relations:
    Hayden IR
    Brett Maas
    646/536-7331
    Email Contact

    For The Company:
    BioNeutral Group Inc.
    Stephen J. Browand
    President and CEO
    973-286-2899
    Email Contact

    For Marketing Agency:
    Wahlrich Group, LLC.
    500 West 37th Street
    New York, NY 10018
    212-736-1717
    Email Contact